Kazia Presents Further Paxalisib Data At Sno, Confirming Earli...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SYDNEY, Nov. 18, 2020 /PRNewswire-AsiaNet/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share a summary of new paxalisib data presented at the Society for Neuro-Oncology (SNO) Annual Meeting, which is being held vi...
Authors: LATEST ASIANET NEWS RELEASES